Evaluation of Essential Metal Metabolism (META-GCA)

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Active, not recruiting

Conditions: Alteration of Metabolism; Essential Metals; Disturbance of Consciousness

Treatments: Other: peripheral venous blood samples, these will be performed in order to measure the biological markers in the serum

Study type: Observational

Funder types: Other

Identifiers

NCT06911515

6279

Details and patient eligibility

About

Disturbance of consciousness (DoC) is a state in which consciousness is altered following brain damage and can manifest in several conditions that result from the loss of regulation of the neural function of the two components of consciousness, alertness and awareness.

It is known that the main causes of disorders of consciousness have important effects on the disruption of essential metal homeostasis.

In particular, myocardial infarction and heart failure, ischemic and hemorrhagic stroke and head trauma trigger phenomena of diffuse axonal damage, hypoxia and re-perfusion that profoundly alter the metabolism of cerebral O2 that reacts with essential metals , in Fenton-type reactions whose predominant effect is an extensive production of reactive oxygen species (ROS) and pro-oxidant molecules.

Fe, Cu and zinc (Zn) are essential metals for life: two thirds of the proteins in our body use these metals that play a crucial role as catalysts or structural elements of proteins in various biological processes, such as cellular respiration in mitochondria, the production and maturation of red and white blood cells, the elasticity of connective tissue, the production of myelin and the production of some neurotransmitters. For this reason, the biology of essential metals has a major impact on our health and the disruption of their homeostasis inexorably leads to disease.

These metals are very important for the metabolism of the Central Nervous System (CNS) and Cu, in particular, even in adults, is involved in the production of myelin and in the production of some neurotransmitters of the diffuse modulatory systems . Cu is a cofactor of the enzymes dopamine β-hydroxylase, and monoamine oxidase involved in the balance of catecholamines , and is altered in some disorders of Cu metabolism.

Enrollment: 120 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have been in a coma state, documented with a GCS ≤ 8 for at least 24 hours;

  • Presence of a disturbance of consciousness, identified through the Coma Recovery Scale-revised (CRS-r) and classified as coma, vegetative state or minimally conscious state;
  • Latency of the acute event between 15 days and 6 months;
  • Ability of the caregiver/guardian to understand and sign the informed consent.

Exclusion criteria

• Age <18 years;

  • Psychiatric or other pathologies;
  • Inflammatory state related to ongoing infections;
  • Refusal or inability to sign the written informed consent to participate in the study.

Trial design

120 participants in 2 patient groups

Experimental: Gruop A

Description:

Difference in metal concentrations (7 metals) in GCA subjects compared to those in previously acquired sera of healthy controls.

Treatment:

Other: peripheral venous blood samples, these will be performed in order to measure the biological markers in the serum

Experimental: Group B: Differences and Correlation

Description:

Differences in essential metal concentrations at 30 days compared to baseline in GCA patients. * Baseline differences in essential metal metabolism in subcategories of patients with impaired consciousness (coma/VS vs MCS, traumatic brain injury vs non-traumatic brain injury). * Correlation between clinical scales and essential metal metabolism

Treatment:

Other: peripheral venous blood samples, these will be performed in order to measure the biological markers in the serum